Trial
NCT04826484
Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Urologic Diseases
Intervention
Exparel 133 miligrams per 10 milliliter injection
Why stopped
Met futility threshold at interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-26